chrisvoncsefalvay/vaers-outcomes huggingface dataset:
got very sick; she couldn't eat; loose tarry stools; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from medical information team.  A 89 year-old female patient received bnt162b2 (BNT162B2), administration date 10Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Endometrial cancer" (unspecified if ongoing); "Stroke" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "got very sick"; FEEDING DISORDER (non-serious), outcome "unknown", described as "she couldn't eat"; DIARRHOEA (non-serious), outcome "unknown", described as "loose tarry stools". The event "got very sick" was evaluated at the physician office visit. Additional information: The patient received the first vaccine on 10Mar2021 and she had all of the side effects the next day but then clarified that they accumulated from Friday to Saturday to Sunday. The patient got very sick. She had a zoom meeting with her primary care provider on Friday, 2 days/48 hours, after the vaccine and everything she was complaining about was common and they said to give it a couple of days. On Sunday, the patient couldn't eat and she had very loose tarry stools. The reporter called the oncology gynecologist nurse because her mother has chosen to have no more treatment (chemo) and she said to go ahead and have the nurses come; it has previously been decided that she would go on hospice if things turned differently. The patient was evaluated to go in the hospice program previously because in January, on her birthday, she had a stroke and came home and had visiting nurses and it was reported that it was coincidental that they were back into this now. The reporter stated no one was totally convinced that she was dying.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I have had an increase heart rate, chest pressure (especially when laying down), night sweats, and shortness of breath, swollen throat) since receiving that second vaccine.  I have gone to urgent care and also a PCP, who have not diagnosed anything, yet.   Everyone thinks it is my anxiety.
Patient with a history of severe anaphylaxis was observed for 30 minutes post vaccine.   Right at  the 30 minute mark, patient started to look pale, started with frequent throat clearing followed by sense of shortness of breath and chest tightness.   2:37p: No wheezing, good air movement, breathing was not labored, no cyanosis, no noted lip or tongue edema, able to speak.  BP 160/54. P 98, O2 sat 98%.  Severity of symptoms per patients = 8/10 "tightness" at time of medical evaluation/medical provider response.  2:38p 911 called, 2:39p epipen, benadryl 50mg oral, and solumedrol 125mg IM administered (patient tolerated well, able to swallow) 2:42p patient reports symptoms improved to ~4/10 severity  O2 sat 98%, P97 2:46p , O2 96%, P 99, BP 148/52 2:48p patient reports symptoms still at ~4/10 severity/stopped improving, O2 sat 95%, p 85; discussed option of doing 2nd epipen 2:54p EMS arrived prior to administration of second epipen.  Patient transported to Emergency Department for further evaluation  for possible anaphylaxix
Sore right injection site arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore right injection site arm) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Sore right injection site arm). At the time of the report, VACCINATION SITE PAIN (Sore right injection site arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication information provided. No Concomitant medication information provided.
Narrative: 75yo male in home hospice for end stage lung cancer died on 9/2/2021. Pt had received covid vaccines on 2/23/20 &3/23/21. This death is likely not related to the vaccinations due to comorbidities, age, and length of time from vaccine administration.
Information has been received from a physician concerning a 65 year old female (weight 150#, height 63") with drug allergies to MIACALCIN, NAPROSYN and ZITHROMAX who on 15-AUG-2008 at 11:00 am was vaccinated with the first dose of PNEUMOVAX, IM in the right deltoid. Concomitant medications were not reported. There were no illness reported at the time of vaccination. On 15-AUG-2008 at 08:00 pm, the patient developed severe headache, swelling and redness at injection site, throbbing, fever and chills. On 16-AUG-2008, the patient sought unspecified medical attention and was treated with dexamethasone, TORADOL, ROCEPHIN, and vitamin B-12. Subsequently on 18-AUG-2008, the patient recovered from severe headache, swelling at injection site, redness at injection site, throbbing, fever and chills. The causality of the events were not reported. Additional information has been requested.
Child was administered DTaP & IPV on 08/22/01 during WCC concurrent mild pharyngitis, no fevers. On 08/23/01, seizure activity lasting 30-60 seconds, consisting of eyes rolling back, eyes and mouth wide open, unresponsive, no tonic clonic activity. Called 911, brought to the ER, temp 104. Labs: CT head within normal limits, med pharyngitis. Suspect febrile seizure, possible vaccine reaction.
After first dose, only pain at injection site, mild headache. After second dose, severe headache that lasted 48 hours, body aches during first 24 hours. Treated with 100mg Motrin every 8 hours.
pt recv vax & 3 hr later pt devel dizziness, felt very lethargic until 27OCT94; the following day pt devel a fever of 104 & skin felt sensitive; There were no complaints of arthralgias, abd pain, nausea or vomiting;
This spontaneous report as received from registered nurse via field representative refers to a 80 year old female patient, who is a mother of the reporter. The patient's pertinent medical history included with diabetes and hypertension. Approximately on an unknown date of 2009, reported as about 5 years ago the patient was vaccinated with ZOSTAVAX (dose, frequency, lot#, route not reported). No concomitant medications reported. Approximately on JUNE-2014, reported as about a month ago, the patient started getting pain and currently has a case of shingles that almost looks like poison ivy. The outcome of shingles that almost looks like poison ivy and started getting pain about a month ago were unknown. The field representative had minimal information therefore many drop down fields are unspecified by reporter. Additional information is not expected.
Medication was stored improperly and not viable.  Unknown at the time given.  Unaware of any adverse reaction.
extreme chills, body aches, fever over 100 degrees on day 2, day 3 severe body aches.
Information has been received from a lawyer regarding a case in litigation concerning a female patient (pt) of unknown age. No information was received regarding the pt's past medical history, concurrent conditions, or concomitant medication. In or about September 2016, the pt was inoculated with ZOSTAVAX (dose, route of administration, vaccination site, lot # and expiry date were not specified) by a physician for its intended purpose: the prevention of shingles. On an unknown date, shortly thereafter, the pt suffered from a severe rash. In or Around May 2017, she presented to a hospital for this injury and was diagnosed with shingles. Subsequently, and because of the shingles that the pt had because of ZOSTAVAX, she began having troubles with her ear (unspecified) and had a cyst on her spleen. As a direct and proximate result of Company's defective ZOSTAVAX vaccine, the pt's symptoms have resulted in physical limitations not present prior to using the Company's product. The pt also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of ZOSTAVAX, the pt sustained severe and permanent personal injuries. Further, as a tragic consequence of the Company's wrongful conduct, she suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. The outcome of the events was not recovered. The events were considered to be related to ZOSTAVAX. The events of shingles, troubles with her ear and a cyst on her spleen were considered to be disabling.
Sore arm, tiredness, foggy, fever, nausea, racing heart, pulpultations, diarrhea
TODDLER DID NOT WANT TO BEAR WEIGHT ON HIS LEFT LEG THEN PARENTS FELT HE WAS WALKING WITH A LIMP. THEY CHECKED FOR PAIN BUT DID NOT FEEL IT WAS PAINFUL TO HIM. 6 DAYS LATER THEY FELT HE WAS STILL WALKING ABNORMALLY. THEY TOOK HIM TO THE ER. I HAVE NOT HEARD THE OUTCOME.
Pt seen on 6/20/07 with fever and rash x 3 days. Runny nose and cough. Pt seen on 6/22/07 rash and fever worse. Fussy and vomited x 2 1 day prior to visit.
Patient  presented to clinic for a Moderna booster and  received a (.5ml) full-dose Moderna vaccine . RN attempted to notify patient of error via phone without success.
Pruritus with scattered redness patches, non fluid filled on torso & arm. Face was flush with splotches.
Gave pt ZOSTAVAX and FLUARIX QUAD vaccine. 3 days later pt presented with a red patch and blister on her arm. Pt state not warm and did not bother her. Called 2 days later was getting better but still there.
Low grade fever; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Low grade fever) and VOMITING (Vomiting) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Low grade fever) and VOMITING (Vomiting). At the time of the report, PYREXIA (Low grade fever) and VOMITING (Vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  Based on the current available information and temporal association between the use of the product and the onset date of the reported events, a causal relationship cannot be excluded.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the reported events, a causal relationship cannot be excluded.
Redness and swelling on local leg. Heat, hard to the touch. Tender. Red rash spreading. Treated with anti-histamine, ice, elevation.
The patient was well prior to vaccination (12/17). The day after, he felt mildly unwell and had a low grade fever. The following day, he had a fever of 102.  He received 1L of fluid at Urgent Care and had a BP ion the 80s. Shortly thereafter, he felt palpitations and developed AF. He came to the hospital where he was tachycardia to 200 bpm and hypotensive to SBP70s. He received aggressive fluid resuscitation (4L), IV metoprolol and was started on empiric Abx. Within several hours, the HR lowered, BP increased, and AF spontaneously converted to sinus. He had no dysuria. Curtures so far have not shown growth at our hospital. Urinary culture from urgent care has reportedly shows 20k gram positive cocci.
Sudden onset of fever and chest pain. He was found to have acute pericarditis and pleuritis with pericardial effusion and bilateral pleural effusions. Patient had an episode of paroxysmal atrial flutter, likely related to cardiac inflammation from pericarditis, and was transferred to the CCU. Acute pericarditis and pleuritis are being treated with Colchicine and he is doing well, no more fever or chest pain.
pain at injection sight up into shoulder, erythema, entire arm itching, face flushed.
fever; cough; This is a spontaneous report from a contactable other hcp (patient) reported that a male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced fever and cough. He went to get the covid test and he's waiting for the result. The patient underwent lab tests and procedures which included sars-cov-2 test: unknown results on an unspecified date. He wanted to know if he tested positive, is he still able to get the 2nd dose of vaccine. The outcome of the events was unknown.   Information on the lot/batch number has been requested.
Began to experience extreme fatigue the next day 9/24, by 9/30 in bed all day.  10/1 and 10/2 achy, sore, congested, coughing, runny nose, clear phlegm, no temperature restless at night, cold sweats off and on  10/11 slight improvement with just slight congestion.
This spontaneous report was received from a registered nurse refers to a multiple unspecified patients of unknown demographics. On an unknown dates, the patients were vaccinated with improperly stored VARIVAX with lot # M023382 and expiration date: 11-MAY-2018; strength, dosage and route unspecified. Temperature/time frame was 5.5 Fahrenheit (F) for 4 hours, 45 minutes. There was no previous excursions. No data logger involved. No adverse effects reported. No product quality complaint was involved. No additional information was provided. This is one of two reports received from the same reporter. Additional information has been requested.
Patient blacked out for a little bit and was okay afterward. called 911 and paramedics came and by that time the patient was okay and didn't have any other issues.
Initial report was received from a health care professional on 10 October 2011. A 41-year-old female patient had received a FLUZONE injection in left deltoid, lot number UH467AB on 06 October 2011. On the same day, 2 hours also reported as "4 hours" after vaccine the patient developed a raspy voice. When the patient tried to eat it was hard for the food to go down her throat. The patient course of treatment was BENADRYL. No further information was available at the time of the report. The patient outcome reported as recovered/ resolved on 07 October 2011. Documents held by sender: none.
Racing heart; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: En6200) via an unspecified route of administration in the right arm on 24Feb2021 at 10:00 (at the age of 71-years-old) and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: En6204) via an unspecified route of administration in the right arm on 17Mar2021 at 11:00 (at the age of 71-years-old) as a single dose for COVID-19 immunisation. Medical history included atrial fibrillation, COVID-19 since unknown date and no thyroid. The patient was allergic to lisinopril and tape. Concomitant medications included atenolol (MANUFACTURER UNKNOWN), valsartan (MANUFACTURER UNKNOWN), pravastatin (MANUFACTURER UNKNOWN) and levothyroxine (MANUFACTURER UNKNOWN) all for unknown indications from unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccination. Prior to vaccination, the patient was diagnosed with COVID-19. The patient had not undergone COVID-19 test. Since the vaccination, the patient was not tested for COVID-19. On 25Mar2021 at 15:00 the patient experienced racing heart, also on day after both the vaccinations. The adverse event resulted in a visit to the doctors or other healthcare professional office/clinic. No therapeutic treatment was taken for the reported event. The clinical outcome of the event heart racing was resolved on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. The patient's medical history and concurrent condition was not reported. On 23-MAY-2016 the patient was vaccinated with a dose of ZOSTAVAX (lot # L036823, expired on 24-DEC-2016)(dose, frequency and route unknown). No concomitant therapy was reported. On an unspecified date of May 2016 the patient experienced a large red itchy spot at the injection site, upper arm swelling. The pharmacist has instructed the patient to apply BENADRYL cream or hydrocortisone cream for the itching and oral ibuprofen for the swelling. The patient has recovered from all the events in 2016. The causality was not reported. Pharmacist has requested a lot check. This is one of 4 reports received from the same reporter. Additional information has been requested.
Client states that (L) upper arm vaccination site became progressively more painful, was hard hot to the touch, red and slightly swollen by the time she went to hospital ER for tx. Client received prescription for KEFLEX 500 mg. 1 tab 4x daily which she had not began as of 10:00 am on 3-30-10. No fever noted by clients went to ER 3-29-10 at approx 8:00 pm.
While I was overseas, I experienced the slow onset of cold-like symptoms that included mild head congestion and slightly runny nose. The symptoms were most apparent outdoors, where the weather was cold and damp. When we got back home, the symptoms continued, but I was still able to function. However, I decided to take a home antigen test for the sake of preventing the possible spread of COVID-19, and I got a positive result on 5/23/2023. I had a telehealth visit with my doctor the same day and was prescribed Paxlovid, which I began taking that same day. The symptoms were probably gone within 24 hours, and I felt 100% better when I woke up the morning of 5/24/2023. I took the Paxlovid during the recommended five-day course. I also followed CDC guidance and isolated for five days and then masked in public for five plus days afterwards.
Severe fatigue; Headache; Body aches; Feel like my skin is crawling; Nauseous; Arm is very sore; I feel like I'm dying; This is a spontaneous report from a contactable healthcare professional. A 38-year-old non-pregnant female patient received bnt162b2 (BNT162B2 reported as COVID-19 vaccine), via an unspecified route of administration left arm on an unspecified date (unknown lot number and expiration date) at a single dose; and via an unspecified route of administration left arm on 04Jan2021 18:00 [06:00 PM] (lot number: Eh9899; expiration date: unknown) at a single dose for covid-19 vaccination. The patient's medical history and concomitant medications were not reported. The patient had known allergies to amoxicillin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received the most recent COVID-19 vaccine administered in a hospital. The patient was not diagnosed with COVID-19 prior to vaccination. On 05Jan2021 17:00 [05:00 PM], the patient experienced severe fatigue, headache and body aches- feel like her skin is crawling and was hit by a freight train. The patient has never had a reaction like this before. The patient was also nauseous, and her arm is very sore, but she doesn't even notice since she feeling like she's dying. The patient has not been tested for COVID-19 since the vaccination. The treatment received by the patient for the adverse event included paracetamol (TYLENOL)/ibuprofen around the clock (OTC medication). The patient reported that the events was non-serious. The adverse event resulted in a doctor or other healthcare professional office/clinic visit. The outcome of the event was not resolved.  The following information on the batch/lot number has been requested.
At first just a sore arm.  But the next night, started running fever and got chills.  Also had sore throat, rawness in chest, particularly in bronchial area, was short of breath and very tired.  Fevers were intermittent but recurring several times a day and then temp would drop back to normal.  Chest symptoms worsened with each day.  SEVEN DAYS AFTER THE INJECTION, I developed a large red welt on the arm, about 3 inches in length.  Fever/chills/sore throat/swollen glands lasted TWO WEEKS AND A DAY.  Red welt lasted 8 days.   I am still tired and have a swollen lymph node under my left arm (the arm that was injected).  I NEED ADVICE ABOUT WHETHER TO GET A 2ND DOSE!!  Can someone please contact me??
Anaphylactic reaction; A spontaneous report was received from a physician concerning a 56-year-old, male patient, who received their first of two planned doses of mRNA-1273, and who developed anaphylactic reaction.    The patient's medical history included blindness and severe allergies to shellfish.  Products known to have been used by the patient, within two weeks prior to the event, included Losartan and Melatonin.    On 28 JAN 2021, approximately 15  minutes prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Batch number: 032L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   Patient's wife called to indicate that her husband had an anaphylactic reaction to the mRNA-1273 vaccine. Patient received the vaccine on 28 JAN 2021 in his left arm. Patient's wife indicated that her husband texted her at 3.21 pm to let her know that he has gotten the shot, indicating that he must have received it around 3.19 pm. Patient's wife indicated that around 3.34 pm, patient said he'd had an anaphylactic reaction, that he had administered a shot of epinephrine and that an ambulance was on its way. The patient's wife noted that the reaction happened within 15 minutes or so. Once in the hospital, the patient was administered Pepcid and Steroid orally. Additional treatment medication for the event included the previously epinephrine and a shot of Benadryl.    Action taken with mRNA-1273 in response to the event(s) was not provided/unknown.  The outcome of the event was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the event, a causal relationship cannot be excluded. Patient's significant medical history included severe allergies to shellfish.